AR196979A1 - Procedimiento para la preparacion de una suspension de virus de la enfermedad de marek, exentos de celulas, viables y estables con un elevado titulo - Google Patents

Procedimiento para la preparacion de una suspension de virus de la enfermedad de marek, exentos de celulas, viables y estables con un elevado titulo

Info

Publication number
AR196979A1
AR196979A1 AR23852071A AR23852071A AR196979A1 AR 196979 A1 AR196979 A1 AR 196979A1 AR 23852071 A AR23852071 A AR 23852071A AR 23852071 A AR23852071 A AR 23852071A AR 196979 A1 AR196979 A1 AR 196979A1
Authority
AR
Argentina
Prior art keywords
marek
viable
viruses
disease
suspension
Prior art date
Application number
AR23852071A
Other languages
English (en)
Spanish (es)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of AR196979A1 publication Critical patent/AR196979A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16351—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AR23852071A 1970-11-25 1971-10-18 Procedimiento para la preparacion de una suspension de virus de la enfermedad de marek, exentos de celulas, viables y estables con un elevado titulo AR196979A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9292070A 1970-11-25 1970-11-25
US17061671A 1971-08-10 1971-08-10

Publications (1)

Publication Number Publication Date
AR196979A1 true AR196979A1 (es) 1974-03-08

Family

ID=26786189

Family Applications (1)

Application Number Title Priority Date Filing Date
AR23852071A AR196979A1 (es) 1970-11-25 1971-10-18 Procedimiento para la preparacion de una suspension de virus de la enfermedad de marek, exentos de celulas, viables y estables con un elevado titulo

Country Status (17)

Country Link
JP (1) JPS5750477B1 (enrdf_load_stackoverflow)
AR (1) AR196979A1 (enrdf_load_stackoverflow)
AU (1) AU473436B2 (enrdf_load_stackoverflow)
BE (1) BE775747A (enrdf_load_stackoverflow)
BR (1) BR7107679D0 (enrdf_load_stackoverflow)
CA (1) CA935091A (enrdf_load_stackoverflow)
CH (1) CH581193A5 (enrdf_load_stackoverflow)
DE (1) DE2158293B2 (enrdf_load_stackoverflow)
DK (1) DK130796B (enrdf_load_stackoverflow)
FI (1) FI49522C (enrdf_load_stackoverflow)
FR (1) FR2115379B1 (enrdf_load_stackoverflow)
GB (1) GB1374123A (enrdf_load_stackoverflow)
IE (1) IE35695B1 (enrdf_load_stackoverflow)
IL (1) IL37849A (enrdf_load_stackoverflow)
IT (1) IT1035519B (enrdf_load_stackoverflow)
NL (1) NL7115348A (enrdf_load_stackoverflow)
PH (1) PH11064A (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT71926B (en) * 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
GB2086408B (en) * 1980-10-16 1985-10-09 Oreal New nitro-derivatives of the benzene series the process for their preparation and their use in the dyeing of keratin fibres
JPS6314729A (ja) * 1986-06-30 1988-01-21 スミスクライン・バイオロジカルス・ソシエテ・アノニム 生ワクチン用改良安定剤、その製造法およびそれを含有するワクチン
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病２価生ワクチンとその製造方法

Also Published As

Publication number Publication date
CA935091A (en) 1973-10-09
IE35695B1 (en) 1976-04-28
FR2115379A1 (enrdf_load_stackoverflow) 1972-07-07
NL7115348A (enrdf_load_stackoverflow) 1972-05-29
DK130796B (da) 1975-04-14
CH581193A5 (enrdf_load_stackoverflow) 1976-10-29
DK130796C (enrdf_load_stackoverflow) 1975-10-06
FR2115379B1 (enrdf_load_stackoverflow) 1977-01-07
BE775747A (fr) 1972-05-24
BR7107679D0 (pt) 1973-07-03
FI49522B (enrdf_load_stackoverflow) 1975-04-01
AU3442071A (en) 1973-04-19
AU473436B2 (en) 1976-06-24
IT1035519B (it) 1979-10-20
GB1374123A (en) 1974-11-13
IL37849A0 (en) 1971-12-29
FI49522C (fi) 1975-07-10
DE2158293B2 (de) 1979-01-25
IE35695L (en) 1972-05-25
IL37849A (en) 1975-04-25
JPS5750477B1 (enrdf_load_stackoverflow) 1982-10-27
PH11064A (en) 1977-10-25
DE2158293A1 (de) 1972-06-08

Similar Documents

Publication Publication Date Title
ES496358A0 (es) Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.
AT304473B (de) Verfahren zur Herstellung von neuen substituierten 1-Amino-2-hydroxy-3-[2'-cyclopentyl- bzw. (δ<2>-cyclopentenyl)-phenoxy]-propanen, deren optisch aktiven Isomeren und Salzen
AR198639A1 (es) Procedimiento para preparar 2,3- cis -1, 2, 3, 4-tetrahidro-5-<2-hidroxi-3-amino substituido propoxi>-2,3-naftalenodioles
AR196979A1 (es) Procedimiento para la preparacion de una suspension de virus de la enfermedad de marek, exentos de celulas, viables y estables con un elevado titulo
DK133311C (da) Fremgangsmade til fremstilling af en vaccine til bekempelse af marek's syge indeholdende levende ikke-svekket,celleassocieret virus
AR205581A1 (es) Procedimiento para preparar 9,3", 4" - tri - alcanoil sf - 837 m1
AR192229A1 (es) Procedimiento y maquina para la fabricacion de tubos de fibrocemento,con orientacion de fibras
AR201704A1 (es) Procedimiento para la preparacion del 1-<4-(2-metil-tioetoxi)-fenoxi> -2-hidroxi-3isopropilaminopropano
AR201114A1 (es) Procedimiento para la elaboracion de nuevas aza -10,11-dihidro 5-h-dibenzo<b,e>-<1,4>-diazepinas
AR202999A1 (es) Procedimiento para la preparacion de 1,4-ioxido de 2-(2oxazolin-2-il)-3-metilquinoxalina
BE773644A (fr) Procede de fabrication d'emballages de formes differentes, deplies et rendus rigides au moment de leur mise en oeuvre
IT7829209A0 (it) Prodotto di condensazione ottenuto da fenotiazina e da p-nitrosofenolo, procedimento per la preparazione del prodotto di condensazione, procedimento per lapreparazione di coloranti allo zolfo con impiego del prodotto di condensazione e i coloranti allo zolfo preparati.
SU490987A1 (ru) Уравнительный механизм дл выравнивани нагрузки
AR201878A1 (es) Procedimiento para preparar una vacuna inmunizante y no patogena
BR7307024D0 (pt) Novo processo de preparacao das alcoil-5 dihidro-10,11 dibenzeno <b,f> azepinas
TR17624A (tr) 1-alkilidenaminourasiller,bunlarin hazirlanmasina mahsus usul ve bunlarin herbisid olarak kullanilmasi
NL142993B (nl) Werkwijze om een suspensie van dierlijke cellen te bereiden, en daarmee een virus-vaccin.
SU940848A1 (ru) Способ электродинамической сепарации
AU456693B2 (en) Improvements; in virus vaccines
BE769130A (fr) Benzothietane-2-spiro-2'-(1',3'-diazocycloalkanes) et leur preparation
BE766870A (fr) Benzimidazoles, leur preparation et leur utilisation comme agents acaricides
MX5864E (es) Procedimiento mejorado para la preparacion de derivados del 2-bromo-ergoleno y del 2-bromo-ergolino
AR201121A1 (es) Procedimiento para la preparacion de 2,2'-anhidro-1beta-d-arabinofuranosil-5-fluorocitosina
AU2793971A (en) Marek's disease inactivated vaccine and process for preparing the same
Brown et al. Pyrolytic generation of acyloxycarbenes and their rearrangement to 1, 2-diketones